Celldex Therapeutics, Inc. Business Finance Contracts & Agreements

36 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Underwriting Agreement, dated July 13, 2021, by and between Celldex Therapeutics, Inc. and Jefferies LLC and SVB Leerink LLC, as representatives of the underwriters named therein
Underwriting Agreements
Celldex Therapeutics, Inc.
Biotechnology
NY
2021
Celldex Therapeutics, Inc. Form of Restricted Stock Unit Award Agreement
Stock Agreements
Celldex Therapeutics, Inc.
Biotechnology
DE
2021
Celldex Therapeutics, Inc. Form of Nonqualified Stock Option Grant Agreement
Stock Agreements
Celldex Therapeutics, Inc.
Biotechnology
DE
2021
Celldex Therapeutics, Inc. Form of Restricted Stock Award Agreement
Stock Agreements
Celldex Therapeutics, Inc.
Biotechnology
DE
2021
Underwriting Agreement, dated June 15, 2020
Underwriting Agreements
Celldex Therapeutics, Inc.
Biotechnology
NY
2020
Celldex Therapeutics, Inc. Amended and Restated 2004 Employee Stock Purchase Plan (effective as of June 19, 2019)
Stock Agreements
Celldex Therapeutics, Inc.
Biotechnology
2019
Specimen of Common Stock Certificate
Stock Agreements
Celldex Therapeutics, Inc.
Biotechnology
2019
Form of Non-Employee Director Stock Option Agreement
Stock Agreements
Celldex Therapeutics, Inc.
Biotechnology
2018
2004 Employee Stock Purchase Plan, as amended and restated
Stock Agreements
Celldex Therapeutics, Inc.
Biotechnology
2018
CELLDEX THERAPEUTICS, INC. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales Agreement
Stock Agreements
Celldex Therapeutics, Inc.
Biotechnology
NY
2016
7,250,000 Shares Celldex Therapeutics, Inc. Common Stock, $0.001 Par Value per Share UNDERWRITING AGREEMENT
Underwriting Agreements
Celldex Therapeutics, Inc.
Biotechnology
NY
2015
CELLDEX THERAPEUTICS, INC. SUBSCRIPTION AGREEMENT
Subscription Agreements
Celldex Therapeutics, Inc.
Biotechnology
DE
2014
7,000,000 Shares Celldex Therapeutics, Inc. Common Stock, $0.001 Par Value per Share UNDERWRITING AGREEMENT
Underwriting Agreements
Celldex Therapeutics, Inc.
Biotechnology
NY
2013
CELLDEX THERAPEUTICS, INC. 2004 EMPLOYEE STOCK PURCHASE PLAN As amended as of March 6, 2013
Stock Agreements
Celldex Therapeutics, Inc.
Biotechnology
2013
12,000,000 Shares Celldex Therapeutics, Inc. Common Stock, $0.001 Par Value per Share UNDERWRITING AGREEMENT
Underwriting Agreements
Celldex Therapeutics, Inc.
Biotechnology
NY
2013
EXECUTION VERSION SECOND LOAN MODIFICATION AGREEMENT
Loan Agreements
Celldex Therapeutics, Inc.
Biotechnology
MD
2012
10,500,000 Shares Celldex Therapeutics, Inc. Common Stock, $0.001 Par Value per Share UNDERWRITING AGREEMENT
Underwriting Agreements
Celldex Therapeutics, Inc.
Biotechnology
NY
2012
10,000,000 Shares Celldex Therapeutics, Inc. Common Stock, $0.001 Par Value per Share UNDERWRITING AGREEMENT
Underwriting Agreements
Celldex Therapeutics, Inc.
Biotechnology
NY
2011
SECURED PROMISSORY NOTE
Note Agreements
Celldex Therapeutics, Inc.
Biotechnology
2011
JOINDER AND FIRST LOAN MODIFICATION AGREEMENT
Loan Agreements
Celldex Therapeutics, Inc.
Biotechnology
MD
2011
CELLDEX THERAPEUTICS, INC. 5,000,000 Shares of Common Stock (par value $0.001 per share) Controlled Equity Offeringsm Sales Agreement
Stock Agreements
Celldex Therapeutics, Inc.
Biotechnology
NY
2011
SECURED PROMISSORY NOTE
Note Agreements
Celldex Therapeutics, Inc.
Biotechnology
2011
LOAN AND SECURITY AGREEMENT
Loan Agreements
Celldex Therapeutics, Inc.
Biotechnology
MD
2011
CELLDEX THERAPEUTICS, INC. RESTRICTED STOCK AWARD AGREEMENT
Stock Agreements
Celldex Therapeutics, Inc.
Biotechnology
DE
2010
CELLDEXTHERAPEUTICS, INC. 2004EMPLOYEE STOCK PURCHASE PLAN as amendedand restated effective as of February 24, 2010
Stock Agreements
Celldex Therapeutics, Inc.
Biotechnology
2010
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. TRANSFER AND TERMINATION AGREEMENT DATED AS OF APRIL...
Exchange Agreements
Celldex Therapeutics, Inc.
Biotechnology
NY
2010
CURAGEN CORPORATION AS ISSUER THE BANK OF NEW YORK, AS TRUSTEE UP TO $120,000,000 AGGREGATEPRINCIPAL AMOUNT OF 4.0% CONVERTIBLE SUBORDINATED NOTESDUE 2011 INDENTURE DATED AS OF...
Indenture Agreements
Celldex Therapeutics, Inc.
Biotechnology
NY
2010
AVANT IMMUNOTHERAPEUTICS, INC. COMMON STOCK PURCHASE AGREEMENT
Stock Agreements
Celldex Therapeutics, Inc.
Biotechnology
DE
2008
REDACTED COPYCONFIDENTIAL TREATMENT REQUESTED Redacted portions have been marked with brackets containing asterisks([***]). The redacted portions are subject to a request for...
Exchange Agreements
Celldex Therapeutics, Inc.
Biotechnology
2007
AMENDMENT AGREEMENT TO PURCHASE AGREEMENT
Purchase Agreements
Celldex Therapeutics, Inc.
Biotechnology
2006
MABVAC , INC. EMPLOYEESTOCK PURCHASE PLAN
Purchase Agreements
Celldex Therapeutics, Inc.
Biotechnology
2005
AMENDMENT NO. 1 TO ASSET PURCHASE AGREEMENT
Purchase Agreements
Celldex Therapeutics, Inc.
Biotechnology
NJ
2005
CELLDEXTHERAPEUTICS, INC. (aDelaware corporation) SHARESOF COMMON STOCK (parvalue $0.01 per share) PURCHASEAGREEMENT
Stock Agreements
Celldex Therapeutics, Inc.
Biotechnology
2005
ConfidentialTreatment Requested As To Certain Information Contained In This Exhibit SECURED PROMISSORY NOTE: EQUIPMENT LOAN SUMMARY OF TERMS ANDDEFINITIONS
Loan Agreements
Celldex Therapeutics, Inc.
Biotechnology
MA
2004
ConfidentialTreatment Requested As To Certain Information Contained In This Exhibit SECURITY AGREEMENT: EQUIPMENT (Dated andeffective as of December 22, 2003)
Security Agreements
Celldex Therapeutics, Inc.
Biotechnology
MA
2004
SUBCONTRACT MODIFICATION
Modification Agreements
Celldex Therapeutics, Inc.
Biotechnology
2003